Cartilage Diseases
Recent clinical, regulatory, research and industry developments relating to this disease.
Mesenchymal stem cells: amazing remedies for bone and cartilage defects.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes3
- Cartilage Diseases1
- Mesenchymal Stem Cells1
- Wharton Jelly1
Leading journals1
- Stem cell research & therapy1
Leading researchers4
- Kangari P1
- Razeghian-Jahromi I1
- Razmkhah M1
- Talaei-Khozani T1
Affiliations (unnormalised)4
- Cardiovascular Research Center1
- School of Advanced Technologies in Medicine1
- Shiraz Institute for Cancer Research1
- Tissue Engineering Laboratory1
Associated genes
Genes associated with this disease in the canonical knowledge graph (Open Targets evidence). Number shows the association score.
Disease biology
Proteins whose encoding gene is associated with this disease, reached through the canonical gene→disease graph. Number shows the gene's association score.
Reference
Authoritative identity, definition & identifiers.
Pathological processes involving the chondral tissue (CARTILAGE).
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.